Modifying the Fc Asn297 Glycan of Human IgG2 Subclass for Improved Antibody Therapeutics and Design of Site-Specific Antibody Drug Conjugates
MetadataShow full item record
- Dissertations 
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.